Search

Your search keyword '"Riociguat, exercise response"' showing total 2 results
Start Over Descriptor "Riociguat, exercise response" Topic balloon pulmonary angioplasty
2 results on '"Riociguat, exercise response"'

1. Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty – A randomized controlled study

Author

Tatsuo Aoki, Koichiro Sugimura, Yosuke Terui, Shunsuke Tatebe, Shigefumi Fukui, Masanobu Miura, Saori Yamamoto, Nobuhiro Yaoita, Hideaki Suzuki, Haruka Sato, Katsuya Kozu, Ryo Konno, Satoshi Miyata, Kotaro Nochioka, Kimio Satoh, and Hiroaki Shimokawa

Subjects
Chronic thromboembolic pulmonary hypertension, Balloon pulmonary angioplasty, Riociguat, exercise response, Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

Background: Although balloon pulmonary angioplasty (BPA) improves symptoms and pulmonary hemodynamics in patients with chronic thromboembolic pulmonary hypertension (CTEPH), the effects of riociguat on hemodynamics and exercise capacity in patients after BPA remain to be elucidated. Methods and Results: This study was a single-center, prospective, randomized, open-label trial. From November 2015 to November 2018, we prospectively examined 21 patients with CTEPH (65 ± 9 years old, M/F 2/19) who showed hemodynamic improvement with mean pulmonary arterial pressure (mPAP)

Published
2020
Full Text
View/download PDF

2. Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty – A randomized controlled study

Author

Hideaki Suzuki, Haruka Sato, Kotaro Nochioka, Masanobu Miura, Tatsuo Aoki, Satoshi Miyata, Hiroaki Shimokawa, Shigefumi Fukui, Saori Yamamoto, Yosuke Terui, Ryo Konno, Katsuya Kozu, Shunsuke Tatebe, Koichiro Sugimura, Nobuhiro Yaoita, and Kimio Satoh

Subjects
medicine.medical_specialty, lcsh:Diseases of the circulatory (Cardiovascular) system, PEA, pulmonary endarterectomy, Haemodynamic response, mPAP, mean pulmonary arterial pressure, medicine.medical_treatment, CO, cardiac output, Chronic thromboembolic pulmonary hypertension, Hemodynamics, 030204 cardiovascular system & hematology, PVR, pulmonary vascular resistance, Balloon, Riociguat, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Angioplasty, medicine, Balloon pulmonary angioplasty, 030212 general & internal medicine, CI, Cardiac index, PAWP, pulmonary arterial wedge pressure, Beneficial effects, Original Paper, HR, heart rate, business.industry, BP, Arterial blood pressure, BPA, Balloon pulmonary angioplasty, Riociguat, exercise response, lcsh:RC666-701, 6MWD, 6-min walk distance, Cardiology, CTEPH, Chronic thromboembolic pulmonary hypertension, RAP, right atrial pressure, PAH, pulmonary arterial hypertension, Cardiology and Cardiovascular Medicine, business, RVEF, right ventricular ejection fraction, medicine.drug
Abstract

Background: Although balloon pulmonary angioplasty (BPA) improves symptoms and pulmonary hemodynamics in patients with chronic thromboembolic pulmonary hypertension (CTEPH), the effects of riociguat on hemodynamics and exercise capacity in patients after BPA remain to be elucidated. Methods and Results: This study was a single-center, prospective, randomized, open-label trial. From November 2015 to November 2018, we prospectively examined 21 patients with CTEPH (65 ± 9 years old, M/F 2/19) who showed hemodynamic improvement with mean pulmonary arterial pressure (mPAP)

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results